Overview
Senocore specializes in distributing equipment for breast disease diagnosis and treatment, as well as oncological surgery. Its products include equipment for breast biopsy and lymphatic system diagnostics, including Fluobeam® LM.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 296 days for 2023).
- 2025not filed
- 202420/04/2026
- 202307/05/2025
- 202229/06/2023
- 202129/06/2022
- 202030/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
News
Senocore supports young athletes and cancer fight – thanks from Kraków Kings U19
The tenth “Pomeranian Breast Surgery Workshops” at the Specialist Hospital in Słupsk are behind us!
Senocore supports the publication of the book “Breast Surgery”
Better visualization of fluorescence imaging thanks to Fluobeam®LM
Vacuum-assisted breast biopsy workshop under ultrasound guidance: Legnica 21.11.2023
Industry
Offer
- Breast biopsy equipment
- Gamma radiation detectors
- Fluorescence imaging systems
- Breast markers
- Collagen matrices
- Biological meshes
- Nipple-areola implants
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Analytics and marketing
- Google Tag Manager
Authorized Representatives
Manner of representation
For representing the company externally, making declarations of will and signing them on behalf of the company: in the case of a one-person management board, the member of the management board is authorised independently; in the case of a multi-member management board, two members of the management board acting jointly are authorised.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Daniel Maliszewskiage 43 | 50 | $675.31 | 50% |
| 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-09-18.
17 1750 1240 0000 0000 3794 9892- 27 1750 1240 0000 0000 3794 9906
05 1050 1722 1000 0090 8115 5179
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,116$1,116 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $624$624 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,345$1,345 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Metabiosp. z o.o. | $228,793.61 | metabio.pl | ||
| BL Medicasp. z o.o. | $148,305.98 | blmedica.pl | ||
| Screenmedsp. z o.o. | $147,401.05 | screenmed.pl | ||
| Medsignalsp. z o.o. | $73,978.71 | medsignal.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| Medsonicsp. z o.o. | $58,155.25 | medsonic.pl | ||
| Opencardiosp. z o.o. | $53,320.79 | opencardio.pl | ||
| Spring Softwaresp. z o.o. | $15,642.34 | springsoftware.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Optotechsp. z o.o. | $4,520.39 | optotech.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-09-20 | Share capital change (5,000,000.00 PLN → 5,000.00 PLN) | |
| 2017-08-30 | Entered in the register |
FAQ
Last updated: 2026-04-24